Restore Mind Medicine

Overemphasis on Commercialization We contend that MindMed's focus on commercialization while being apparently six or more years away from product launch is not an efficient use of resources. र्ट MindMed's commercialization team consists of a Chief Commercial Officer, two product managers, and one Director of Product & Product Life Cycle. MindMed has an open position for a Sr. Director for Global Marketing. All current personnel were hired before April 2022, prior to MindMed's Phase IIb starting This is the team needed when a company is 12-18 months from launch. Although MindMed justifies a large commercial group because of the novelty of psychedelics, in fact, there will likely be 2+ psychedelics already approved if/when MindMed launches a drug product. We believe it is important to have commercial input early on in drug development. We plan to retain the CCO as a consultant on a part-time basis with a budget for additional consultants to support projects on an ad-hoc basis. Source: Company SEDAR Filings, Company SEC Filings. See [13] late August. 51

View entire presentation